AU2022379998A1 — Methods for administration of drug to the retina
Assigned to Georgia Tech Research Corp · Expires 2024-05-09 · 2y expired
What this patent protects
Methods are provided for administering a therapeutic agent to an eye of a patient, wherein the method includes (i) inserting a microneedle into the eye of the patient, wherein the microneedle extends through the sclera and choroid layers, but not into the vitreous, and without a …
USPTO Abstract
Methods are provided for administering a therapeutic agent to an eye of a patient, wherein the method includes (i) inserting a microneedle into the eye of the patient, wherein the microneedle extends through the sclera and choroid layers, but not into the vitreous, and without a vitrectomy or a retinotomy; and (ii) injecting a fluid comprising a therapeutic agent through a lumen of the microneedle and into a subretinal space of the eye, wherein the microneedle has (i) a beveled tip with a bevel angle from 40º to 70º and (ii) an outer diameter that is less than 150 µm.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.